Helen Rizos Selected Research

Transcription Factors (Transcription Factor)

11/2014	Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151.
4/2014	Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Helen Rizos Research Topics

Disease

85	Melanoma (Melanoma, Malignant) 05/2024 - 04/2005
56	Neoplasms (Cancer) 12/2023 - 02/2003
9	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2012
5	Uveal melanoma 02/2024 - 11/2018
4	Disease Progression 11/2020 - 07/2013
4	Nevus (Nevi) 01/2019 - 08/2009
2	Glioblastoma (Glioblastoma Multiforme) 11/2021 - 11/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 11/2008
2	Dementia (Dementias) 11/2012 - 06/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2012 - 06/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2007 - 12/2006
2	Nervous System Neoplasms (Neoplasms, Nervous System) 07/2007 - 12/2006
1	Residual Neoplasm 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Anus Neoplasms (Anal Cancer) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Fever (Fevers) 01/2019
1	Monosomy 11/2018
1	Carcinoma (Carcinomatosis) 01/2017

Drug/Important Bio-Agent (IBA)

19	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2020 - 07/2012
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2009
14	Immune Checkpoint InhibitorsIBA 08/2023 - 01/2015
14	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2013
10	Circulating Tumor DNAIBA 01/2022 - 12/2015
10	Tumor Suppressor Protein p14ARF (p14ARF)IBA 10/2020 - 02/2003
9	dabrafenibIBA 05/2024 - 07/2012
8	trametinibIBA 05/2024 - 07/2013
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2013
7	Mitogen-Activated Protein KinasesIBA 01/2021 - 07/2013
6	Phosphotransferases (Kinase)IBA 01/2020 - 01/2013
6	VemurafenibIBA 12/2015 - 12/2012
5	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2011 - 10/2008
4	CytokinesIBA 01/2023 - 11/2014
4	Proto-Oncogene Proteins B-rafIBA 08/2015 - 07/2012
3	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2018
3	AntigensIBA 01/2023 - 11/2020
3	Cell-Free Nucleic AcidsIBA 11/2020 - 02/2019
3	Small Interfering RNA (siRNA)IBA 11/2020 - 11/2008
3	GSK1210151AIBA 10/2020 - 11/2014
3	Messenger RNA (mRNA)IBA 11/2012 - 11/2008
2	Protein Kinase CIBA 02/2024 - 04/2021
2	ChemokinesIBA 01/2023 - 11/2014
2	InterferonsIBA 10/2022 - 01/2018
2	LigandsIBA 10/2022 - 10/2022
2	Histocompatibility Antigens Class IIBA 06/2021 - 11/2020
2	Programmed Cell Death 1 ReceptorIBA 05/2021 - 01/2018
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021 - 02/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 11/2014
2	IpilimumabIBA 01/2018 - 12/2015
2	AntibodiesIBA 01/2018 - 06/2010
2	CateninsIBA 10/2017 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 11/2014 - 04/2014
2	Glucose (Dextrose)FDA LinkGeneric 04/2014 - 02/2014
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2013 - 11/2005
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 08/2009 - 07/2007
1	Checkpoint Kinase 1IBA 08/2023
1	Hydroxyurea (Hydrea)FDA LinkGeneric 08/2023
1	Differentiation AntigensIBA 01/2023
1	Protein Kinase InhibitorsIBA 10/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	Chloroquine (Aralen)FDA LinkGeneric 01/2022
1	InflammasomesIBA 01/2022
1	Peptides (Polypeptides)IBA 06/2021
1	HLA-DR Antigens (HLA-DR)IBA 05/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2021
1	antiglomerular basement membrane antibodyIBA 11/2020
1	Apoptosis Regulatory ProteinsIBA 10/2020
1	S63845IBA 10/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Nucleic AcidsIBA 02/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	Alanine (L-Alanine)FDA Link 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	ParaffinIBA 01/2019
1	Serine (L-Serine)FDA Link 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 01/2019
1	Dual Specificity Phosphatase 6IBA 01/2019
1	RNA Splicing FactorsIBA 11/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2018
1	Peptide Initiation Factors (Initiation Factor)IBA 11/2018
1	Tumor Biomarkers (Tumor Markers)IBA 01/2018
1	PanobinostatIBA 01/2018
1	CaspasesIBA 01/2018
1	Histone Deacetylase InhibitorsIBA 01/2018
1	encorafenibIBA 01/2018
1	Therapeutic UsesIBA 06/2017
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2017
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2017
1	Blood Proteins (Serum Proteins)IBA 01/2017
1	NivolumabIBA 12/2015
1	pembrolizumabIBA 12/2015

Therapy/Procedure

34	Therapeutics 05/2024 - 07/2012
19	Immunotherapy 08/2023 - 01/2014
5	Drug Therapy (Chemotherapy) 01/2022 - 11/2008
2	Precision Medicine 12/2023 - 12/2012
2	RNAi Therapeutics 11/2021 - 11/2020
2	Neoadjuvant Therapy 01/2019 - 01/2019
1	Salvage Therapy 01/2023
1	Radiotherapy 01/2020